Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Revisiting Foam Sclerotherapy: Challenging the 7 mm Dogma
Haroun Gajraj/LinkedIn
Oct 25, 2025, 07:46

Revisiting Foam Sclerotherapy: Challenging the 7 mm Dogma

Haroun Gajraj, a Self-Employed Phlebologist, posted on LinkedIn.

”An excellent demonstration of the utility of Foam Sclerotherapy for Superficial Venous Disease.

Dogma (aka Guidelines) tells us that Foam is only useful for veins up to 7 mm.

Even then, long-term durability is widely thought to be inferior to endothermal ablation.

Thank you Massimo Pozza for sharing your expertise.

Those who get inferior results are not doing it right. Simple as that!”

Quoting Massimo Pozza‘s post:

” This is a very interesting case because the patient had a VGS dilation of about 2.4 cm at 30 cm from the crosse (average diameter calculated on the teaching of Dr. Sica of Paris) with this abnormal antero-medial collateral.
I treated the VGS with direct puncture to the middle lower III of the thigh with 1% R L/A 1/4 foam about 8cc and then I treated the coarse collateral with atxscl 0.5/0.7% foam at the control after about 6 years the patient does not have recanalization of either the VGS or the coarse collateral and I limited myself to the treatment of some small collateral legs.

This is to highlight the
The fact is that very often it is enough to use delicate concentrations to have excellent results and that I prefer to use more aggressive concentrations depending on the patient’s response, which is different from person to person.
I always use Nadiax 3 nanoemulsion cream before and after the treatment and in this case elastocontension 35 mmHg for 7 days.”

” Sclerotherapy

Stay updated with Hemostasis Today.

bleeding disorders Haroun Gajraj Health Hematology Hemostasis Hemostasis Today Massimo Pozza Medicine sclerotherapy Superficial Venous Disease thrombosis
NewsFeed